Xenon Pharmaceuticals Inc (XENE)
40.59
+0.25
(+0.62%)
USD |
NASDAQ |
Apr 19, 10:20
Xenon Pharmaceuticals Total Liabilities (Quarterly): 36.88M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.88M |
| September 30, 2023 | 34.50M |
| June 30, 2023 | 38.44M |
| March 31, 2023 | 32.92M |
| December 31, 2022 | 32.65M |
| September 30, 2022 | 22.69M |
| June 30, 2022 | 21.59M |
| March 31, 2022 | 16.21M |
| December 31, 2021 | 21.97M |
| September 30, 2021 | 15.41M |
| June 30, 2021 | 17.73M |
| March 31, 2021 | 14.39M |
| December 31, 2020 | 17.83M |
| September 30, 2020 | 17.10M |
| June 30, 2020 | 21.38M |
| March 31, 2020 | 49.06M |
| December 31, 2019 | 55.72M |
| September 30, 2019 | 24.34M |
| June 30, 2019 | 23.10M |
| March 31, 2019 | 22.24M |
| Date | Value |
|---|---|
| December 31, 2018 | 19.13M |
| September 30, 2018 | 19.30M |
| June 30, 2018 | 14.82M |
| March 31, 2018 | 9.264M |
| December 31, 2017 | 10.19M |
| September 30, 2017 | 3.058M |
| June 30, 2017 | 3.774M |
| March 31, 2017 | 3.591M |
| December 31, 2016 | 3.586M |
| September 30, 2016 | 4.062M |
| June 30, 2016 | 3.03M |
| March 31, 2016 | 2.989M |
| December 31, 2015 | 2.915M |
| September 30, 2015 | 5.485M |
| June 30, 2015 | 12.18M |
| March 31, 2015 | 10.43M |
| December 31, 2014 | 14.64M |
| September 30, 2014 | 19.16M |
| June 30, 2014 | 23.61M |
| December 31, 2013 | 30.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.39M
Minimum
Mar 2021
55.72M
Maximum
Dec 2019
27.05M
Average
22.69M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| ESSA Pharma Inc | 3.806M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 964.80M |
| Shareholders Equity (Quarterly) | 927.92M |